March 21, 2018 / 11:00 AM / a month ago

BRIEF-Boston Scientific Announces Agreement To Acquire NxThera

March 21 (Reuters) - Boston Scientific Corp:

* BOSTON SCIENTIFIC ANNOUNCES AGREEMENT TO ACQUIRE NXTHERA

* BOSTON SCIENTIFIC CORP - ‍TRANSACTION CONSISTS OF AN UPFRONT CASH PAYMENT OF $306 MILLION​

* BOSTON SCIENTIFIC CORP - DEAL OF NXTHERA IS EXPECTED TO BE IMMATERIAL TO BOSTON SCIENTIFIC ADJUSTED EPS THROUGH 2020 AND ACCRETIVE THEREAFTER​

* BOSTON SCIENTIFIC - ‍TRANSACTION ALSO CONSISTS OF UP TO ADDITIONAL $100 MILLION IN POTENTIAL COMMERCIAL MILESTONE PAYMENTS OVER NEXT FOUR YEARS​

* BOSTON SCIENTIFIC CORP - DEAL IS EXPECTED TO BE DILUTIVE ON A GAAP BASIS, DUE TO AMORTIZATION AND TRANSACTION AND INTEGRATION COSTS​

* BOSTON SCIENTIFIC - CO HAS EXISTING MINORITY INVESTMENT IN NXTHERA, EXPECTED TO RESULT IN UPFRONT PAYMENT OF ABOUT $240 MILLION & MILESTONE PAYMENTS OF UP TO $85 MILLION​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below